Evaluation of the Performance Characteristics of a New POC Multiplex PCR Assay for the Diagnosis of Viral and Bacterial Neuromeningeal Infections
- PMID: 36980418
- PMCID: PMC10047878
- DOI: 10.3390/diagnostics13061110
Evaluation of the Performance Characteristics of a New POC Multiplex PCR Assay for the Diagnosis of Viral and Bacterial Neuromeningeal Infections
Abstract
Point-of-care syndromic PCR (POC SPCR) assays are useful tools for the rapid detection of the most common causative agents of community-acquired infections responsible for meningitis and encephalitis infections. We evaluated the performance characteristics of the new QIAstat-Dx® Meningitis/Encephalitis panel (QS) compared to the laboratory reference methods and the POC SPCR Biofire® FilmArray® Meningitis Encephalitis Panel (FA). Viral (Enterovirus, Parechovirus, HSV-1, HSV-2, HHV-6, VZV) and bacterial (E. coli K1, H. influenzae, L. monocytogenes, encapsulated N. meningitidis, M. pneumoniae, S. agalactiae, S. pneumoniae, S. pyogenes) pathogens were suspended at low concentrations and tested with the POC SPCR systems. The reproducibility, analytical specificity, carryover contamination, interferences and clinical samples were evaluated. All samples tested positive with both QS and FA except for those containing the lowest concentrations of Enterovirus-D68-B3, Echovirus-30 and S. agalactiae which were only detected by FA. In terms of analytical specificity, we observed 3 false positive results out of 48 QS tests versus 1 out of 37 FA tests. For the other studied criteria, both QS and FA performed as expected. Our results suggest that the performance characteristics of QS are close to those of FA. A prospective multicenter study would be useful to complete the performances evaluation of QS.
Keywords: PCR; bacteria; cerebrospinal fluid; encephalitis; meningitis; point of care; syndromic; virus.
Conflict of interest statement
The corresponding author states on behalf of all the authors that all potential conflicts of interest have been disclosed.
Figures
References
-
- Choi J.J., Westblade L.F., Gottesdiener L.S., Liang K., Li H.A., Wehmeyer G.T., Glesby M.J., Simon M.S. Impact of a multiplex polymerase chain reaction panel on duration of empiric antibiotic therapy in suspected bacterial meningitis. Open Forum Infect. Dis. 2021;8:ofab467. doi: 10.1093/ofid/ofab467. - DOI - PMC - PubMed
-
- Hoen B., Varon E., de Debroucker T., Fantin B., Grimprel E., Wolff M., Duval X., Expert and Reviewing Group Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments. Med. Mal. Infect. 2019;49:405–441. doi: 10.1016/j.medmal.2019.03.009. - DOI - PubMed
-
- Menasalvas-Ruiz A.I., Salvador-Garcia C., Moreno-Docon A., Alfayate-Miguelez S., Perez Canovas C., Sanchez-Solis M. Enterovirus reverse transcriptase polymerase chain reaction assay in cerebrospinal fluid: An essential tool in meningitis management in childhood. Enferm. Infecc. Microbiol. Clin. 2013;31:71–75. doi: 10.1016/j.eimc.2012.07.007. - DOI - PubMed
-
- Trujillo-Gomez J., Tsokani S., Arango-Ferreira C., Atehortua-Munz S., Jimenez-Villegas M.J., Serrano-Tabares C., Veroniki A.A., Florez I.D. Biofire Filmarray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis. EClinicalMedicine. 2022;44:101275. doi: 10.1016/j.eclinm.2022.101275. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
